Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
NCT01246232Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Sep 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amisulpride in schizophrenia, sponsored by Imperial College London. Started Sep 2011; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01246232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246232.